Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-348-1 | CAS number: 2421-28-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / bone marrow chromosome aberration
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Reliable scientific study performed under GLP. Similar to OECD 475 (1997); precedes establishments of guideline.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 475 (Mammalian Bone Marrow Chromosome Aberration Test)
- Deviations:
- yes
- Remarks:
- ; 50 cells per sample rather than 100, were analyzed.
- GLP compliance:
- no
- Type of assay:
- chromosome aberration assay
Test material
- Reference substance name:
- Benzophenone-3,3':4,4'-tetracarboxylic dianhydride
- EC Number:
- 219-348-1
- EC Name:
- Benzophenone-3,3':4,4'-tetracarboxylic dianhydride
- Cas Number:
- 2421-28-5
- Molecular formula:
- C17H6O7
- IUPAC Name:
- 5-(1,3-dioxo-1,3-dihydro-2-benzofuran-5-carbonyl)-1,3-dihydro-2-benzofuran-1,3-dione
- Test material form:
- solid: crystalline
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- 50 albino rats (Cr-1, Sprague-Dawley descended, COB CD [SD] BR, 25 males and 25 females. Acclimated 7 days prior to study initiation, to a diurnal cycle of 12 hours light and 12 hours darkness by automatic timer. Exposures were conducted during the light phase. Animals were housed in cages measuring 4 inches wide by 10 inches long by 7.5 inches high. Food (Purina Lab Chow #5001) and tap water via automatic water fonts were provided ad libitum.
Administration / exposure
- Route of administration:
- inhalation: dust
- Vehicle:
- dry filtered air
- Details on exposure:
- BTDA was generated as a dust using a Wright Dust Feeds. The dust-laden air was mixed with an accessory airflow and passed into the chamber. Wright Dust Feed Gear ratios were adjusted to achieve the desired concentration. See Table 1 in "Any other information on Materials and Methods including Tables."
Animals were exposed (whole body) to test material in a 100-L glass and stainless steel inhalation chamber operated dynamically with dry filtered air. Total airflow into chambers was monitored by flowraters and held at a constant 20 L per minute. Exposure was maintained for 6 hours in duration. Mean temperature and relative humidity for the entire study was 25.5 oC (± 1.0) and 46% (± 6.4).
During inhalation exposures, the animals were individually housed in stainless steel wire-mesh cages within the test chamber. Food and water were not available to the animals during the exposure periods. Animals in the negative control group were exposed to dried filtered air in an identical chamber operated at an airflow of 20 L of air/minute. A positive control group of animals were administered triethylene melamine (TEM) at 0.4 mg/kg in a single ip (5 ml/kg) dose 24 hours prior to sacrifice.
Chamber monitoring: Gravimetric concentration. Three daily gravimetric filter (Gelman DM-450) samples were obtained from each of the test chambers during exposures. The filters were preweighed and the gravimetric concentration was calculated as the weight of material collected per total volume of air sampled. The overall mean concentrations were within 30% of the target levels (see Table 1) for Group 2, 2% for Group 3 and 10% for Group 4.
Aerodynamic particle size measurements of BTDA dust were taken prior to animal exposures with an Andersen 8-stage Impactor operating at a flowrate of 28.4 L/min. Measurements were recorded during exposures with an Andersen 4-stage Mini-Impactor. The average mass median diameter (µ) ranged from 2.65 to 3.24, with a geometric standard deviation (sigma m) ranging from 1.74 to 3.31. Sampling durations were 5 minutes for Group 2, 3 minutes for Group 3 and 1 minute for Group 4. Weight gains on each stage and back-up filters were converted to percentages of the total weight, and back-up filters were analyzed to indicate that the majority of the particles sampled were within the respirable range (<5.0 microns) for all test groups. - Duration of treatment / exposure:
- 6 hours/day
- Frequency of treatment:
- 5 consecutive days
- Post exposure period:
- Animals were observed prior to, at hourly intervals during, and following each daily exposure for evidence of unusual appearance and/or behavior. Observations were recorded. Individual pre- and postexposure weights were recorded for all animals. Group 5 animals were weighed immediately before sacrifice.
On the day following the last administration of the test and control substances, all animals received a single intraperitoneal injection of colchicine (2.0 mg/kg-5.0 ml/kg body weight) in Hank's Balanced Salt Solution (HBSS), pH 7.4, to inhibit mitosis in dividing cells. Approximately two hours after injection of colchicine, the animals were sacrificed by CO2 asphyxiation.
Doses / concentrationsopen allclose all
- Remarks:
- Doses / Concentrations:
BTDA 1 mg/m3
Basis:
analytical conc.
- Remarks:
- Doses / Concentrations:
BTDA 55 mg/m3
Basis:
analytical conc.
- Remarks:
- Doses / Concentrations:
BTDA 3000 mg/m3
Basis:
analytical conc.
- No. of animals per sex per dose:
- 10, 5 males and 5 females
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Triethylene melamine 0.4 mg/kg body weight, as positive control substance administered via a single intraperitoneal injection 24 hours prior to sacrifice.
Examinations
- Tissues and cell types examined:
- bone marrow
- Details of tissue and slide preparation:
- The bone marrow cells were processed according to the modified techniques described by Evans (1976), and Kilian, at al. (1977). Slides were prepared and stained with Giemsa stain (Harleco) in Phosphate Buffer (pH 6.8). Three slides were made for each animal.
Fifty cells in metaphase were examined from each rat (that provided analyzable cells). Chromosomal aberrations as well as stage vernier settings for each metaphase were recorded. The mitotic index (number of cells undergoing mitosis per 100 cells counted) was also recorded for each animal. Chromosomal aberrations were characterized as follows: (1) chromatid breaks; (2) chromosome breaks; (3) markers, which include dicentrics, exchanges, rings, and other miscellaneous configurations; and (4) severely damaged cell, as per Kilian, et al. (1977). The percent of aberrant cells per group was calculated by dividing the total number of aberrant cells/group by the total number of cells observed/group. The average number of aberrations per cell/group was calculated by dividing the total number of aberrations per group by the total number of cells observed for each group. The fold increase in aberrations/cell was determined by dividing the average number of aberrations per cell for each test group by the negative control group value. The number of chromosomes (modal number) was determined for each metaphase spread. - Statistics:
- The mean changes in body weights, the mean mitotic indices and mean modal numbers were analyzed using Bartlett's test for equality of variance (Bartlett, 1937), the one-way classification analysis of variance (Snedecor and Cochran, 1967), and (if a significant ANOVA was reported) Scheffe's multiple F Test procedure (Scheffe, 1953). Significance was established at p ≤ 0.05. The total number of aberrant cells and the total number of aberrations per animal (including chromatid breaks, chromosome breaks, markers, and severely damaged cells) for each group were statistically compared using Wilcoxon's nonparametric comparison of group means (Snedecor and Cochran, 1967).
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- yes
- Remarks:
- 5 animals died during the exposure period
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- All animals in the control group exhibited normal appearance and behavior throughout the study. Animals in the low dose group (1 mg/m3) exhibited normal appearance and behavior throughout the study with the exception of notable sniffing and preening, which occurred approximately one minute after initiation of the Day 5 exposure. Animals in the mid dose group (55 mg/m3) exhibited normal animal appearance and behavior, except for sniffing, preening, and sneezing (3/10 animals) approximately one minute after initiation of the final exposure. Five animals in the high dose group (3000 mg/m3) expired during the exposure periods (three on Day 1, and one each on days 4 and 5). Signs of eye irritation, respiratory distress, agitation, diarrhea, and bloody eye, nose and mouth discharges were recorded at various intervals throughout the remainder of the exposures.
Significant (p ≤ 0.05) decreased terminal body weight and body weight gains were observed for the high dose of BTDA when compared to control animals.
Frequencies of cytogenetic aberrations for animals exposed to 1, 55 and 3,000 mg/m3 BTDA for five consecutive days were similar to the negative control group. As expected, animals administered TEM exhibited a marked increase (p < 0.05) in the number of aberrant cells as well as aberrations/cell. No significant differences between the mitotic indices of the test groups and the negative controls were noted. The positive control (TEM) significantly reduced the mitotic index. The mean modal numbers for all groups were within the expected range (not statistically significant differences from control values).
Any other information on results incl. tables
Table 2: Comparison of Frequencies of Chromosomal Aberrations and Mitotic Index Among Dose Groups
BTDA Dose Group (mg/m3) |
Total No. Cells Analyzed |
% Aberrant Cells |
Average Aberrations per Cell |
Fold Increase of Aberrations per cell |
Mean Mitotic Index (± sd) |
Mean Modal Number/ Animal (± sd) |
0 |
450 |
2.7 |
0.027 |
- |
2.9±0.9 |
41.57± 0.30 |
1 |
350 |
2.0 |
0.023 |
<1 |
2.9±1.1 |
41.25± 0.56 |
55 |
400 |
3.0 |
0.03 |
1.1 |
3.5±1.3 |
41.36± 0.35 |
3000 |
200 |
2.0 |
0.02 |
<1 |
2.5±1.0 |
41.13± 0.60 |
TEM (0.4 mg/kg) |
500 |
21.0 |
0.71 |
26.3 |
1.0±1.2 |
41.60± 0.67 |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
1,3-Isobenzofurandione, 5,5'-carbonylbis- (BTDA) was tested in an in vivo repeated dose inhalation toxicity study in male and female Sprague Dawley rats for evidence of hematopoeitic genotoxicity (chromosomal aberrations). No increase in the frequency of chromosomal aberrations was seen in the bone marrow cells of rats exposed to 1, 55, and 3,000 mg/m3 BTDA for five consecutive days. Toxicity was observed in the animals as weight loss, signs of distress (around the eye, nose and mouth), and death. Mitotic indices and modal numbers for test and negative control groups were not changed. Under the conditions of this study, BTDA did not produce structural mutations in chromosomes in bone marrow cells.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.